Skip to main content
. 2020 Nov 4;12(11):3245. doi: 10.3390/cancers12113245

Figure 4.

Figure 4

Peripheral blood (PB) profiling of different clinical and prognostic groups at the time of diagnosis. Comparisons refer to (A) International Staging System (ISS); (B) cytogenetics; (C) response to therapy; (D) PCA analysis of selected PB subsets according to therapeutic response. * p < 0.05; ** p < 0.01; *** p < 0.001; MDSCs: myeloid-derived suppressor cells; HR: high-risk; LR: low-risk; CR: complete response; VGPR: very good partial response; PR: partial response; PCA: principal component analysis.